Pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites in streptozocin-induced diabetic rats

Attal, 1990, Further evidence for “pain-related behaviors in a model of unilateral peripheral mononeuropathy, Pain, 41, 235, 10.1016/0304-3959(90)90022-6

Bechtel, 1988, The influence of insulin-dependent diabetes on the metabolism of caffeine and the expression of the debrisoquin oxidation phenotype, Clin. Pharmacol. Ther., 44, 408, 10.1038/clpt.1988.173

Bennett, 1988, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33, 87, 10.1016/0304-3959(88)90209-6

Coudoré, 1992, High-performance liquid chromatographic determination of amitriptyline and its main metabolites using a silica column with reversed-phase eluent, J. Chromatogr. Biomed. Applic., 584, 249, 10.1016/0378-4347(92)80582-B

Coudoré, 1994, Mice plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after half-life repeated administration, 8, 525

Coudoré, 1996, Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute and repeated administration to rats, Gen. Pharmacol., 27, 803, 10.1016/0306-3623(95)02082-9

Courteix, 1993, Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, 53, 81, 10.1016/0304-3959(93)90059-X

Courteix, 1994, Study of the sensibility of the diabetes-induced pain model in rats to a range of analgesics, Pain, 57, 153, 10.1016/0304-3959(94)90218-6

Dahl, 1993, Genetically variable metabolism of anti-depressants and neuroleptic drugs in man, Pharmacogenetics, 3, 61, 10.1097/00008571-199304000-00001

Dawling, 1979, Single oral-dose pharmacokinetics of amitriptyline and maprotiline in depressed patients—prediction of steady-state plasma concentrations, Br. J. Clin. pract., 33, 28

Dixon, 1961, The metabolism of drugs by liver microsomes from alloxan-diabetic rats, J. Pharmacol. Exp. Ther., 133, 7

Eschalier, 1988, Pharmacokinetic patterns of repeated administration of antidepressants in animals. I. Implications for antinociceptive action of clomipramine in mice, J. Pharmac. Exp. Ther., 245, 963

Favreau, 1988, Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treatment, Diabetes, 37, 576, 10.2337/diabetes.37.5.577

Ghersi-Egea, 1988, A new aspect of the protective function of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels, Life Sci., 42, s1523, 10.1016/0024-3205(88)90351-7

Hyttel, 1980, Neuropharmacological properties of amitriptyline, nortriptyline and their metabolites, Acta Pharmac. Toxic., 47, 53, 10.1111/j.1600-0773.1980.tb02025.x

Kapitulnik, 1987, Immuno-histochemical localization of cytochrome P450 in rat brain, Neuroscience, 20, 829, 10.1016/0306-4522(87)90243-0

Lequesne, 1986, A study of pain threshold in diabetic with neuropathic foot lesions, J. Neurol. Neurosurg. Psychiat., 49, 1191, 10.1136/jnnp.49.10.1191

Minn, 1991, Drug metabolizing enzymes in the rat brain and cerebral microvessels, Brain Res. Rev., 16, 65, 10.1016/0165-0173(91)90020-9

Miyake, 1990, Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline, J. Pharm. Sci., 79, 192, 10.1002/jps.2600790403

Past, 1982, Drug metabolism in a reconstituted system by diabetes dependent hepatic cytochrome P-450, Res. Comm. Chem. Pathol. Pharm, 37, 81

Potter, 1984, Frontiers in Biochemical and Pharmacological Research in Depression, 373

Reinke, 1978, Altered activity of hepatic mixed-function monooxygenase enzymes in streptozotocin-induced diabetic rats, Xenobiotica, 8, 611, 10.3109/00498257809069573

Rouer, 1986, Immunoquantitation of some cytochrome P-450 in liver microsomes from streptozotocin-diabetic rats, Experientia, 42, 1162, 10.1007/BF01941293

Schultz, 1985, Discrepancies between pharmacokinetic studies of amitriptyline, Clin. Pharmacokin., 10, 257, 10.2165/00003088-198510030-00005

Seltzer, 1990, A novel behavioural model of neuropathic pain disorders produced by partial sciatic nerve injury, Pain, 43, 205, 10.1016/0304-3959(90)91074-S

Shimojo, 1994, Cytochrome P450 changes in rats with streptozocin-induced diabetes, Int. J. Biochem., 26, 1261, 10.1016/0020-711X(94)90095-7

Shimojo, 1993, Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes, Biochem. Pharmac., 46, 621, 10.1016/0006-2952(93)90547-A

Sindrup, 1994, Antidepressants in the treatment of diabetic neuropathy symptoms, Danish Med. Bull., 41, 66

Skett, 1985, Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat, Biochem. Pharmac., 34, 287, 10.1016/0006-2952(85)90139-X

Watkins, 1990, Natural history of the diabetic neuropathy, Quart. J. Med., 77, 1209, 10.1093/qjmed/77.3.1209

Young, 1985, Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs, Diabetic Med., 2, 363, 10.1111/j.1464-5491.1985.tb00652.x

Young, 1991, Hydroxylated metabolites of antidepressants, Psychopharmac. Bull., 27, 521

Ziegler, 1988, Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy, Pain, 34, 1, 10.1016/0304-3959(88)90175-3